Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Sandomenico · SciRah

Researcher profile · Semantic Scholar

C. Sandomenico

Share profile

C. Sandomenico — researcher profile on SciRah

h-index: 20
Works: 64
Citations: 1,264

Most-cited papers

Role of oxaliplatin in the treatment of colorectal cancer
P. Comella, R. Casaretti, C. Sandomenico, A. Avallone +1 more
2009Therapeutics and Clinical Risk Management98 citations Open access
Semantic Scholar
Angiogenesis Inhibitors in NSCLC
A. Manzo, A. Montanino, G. Carillio, R. Costanzo +7 more
2017International Journal of Molecular Sciences95 citations Open access
Semantic Scholar
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
G. Baldassarre, A. Boccia, P. Bruni, C. Sandomenico +7 more
2000Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research69 citations
Semantic Scholar
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1
G. Baldassarre, A. Romano, F. Armenante, M. Rambaldi +8 more
1997Oncogene63 citations
Semantic Scholar
Immunotherapy in Small Cell Lung Cancer
G. Esposito, G. Palumbo, G. Carillio, A. Manzo +16 more
2020Cancers61 citations Open access
Semantic Scholar
RET Inhibitors in Non-Small-Cell Lung Cancer
Priscilla Cascetta, V. Sforza, A. Manzo, G. Carillio +14 more
2021Cancers60 citations Open access
Semantic Scholar
Gefitinib in Non Small Cell Lung Cancer
R. Costanzo, M. Piccirillo, C. Sandomenico, G. Carillio +10 more
2011Journal of Biomedicine and Biotechnology60 citations Open access
Semantic Scholar
Angiogenesis Inhibitors in Small Cell Lung Cancer
A. Montanino, A. Manzo, G. Carillio, G. Palumbo +11 more
2021Frontiers in Oncology55 citations Open access
Semantic Scholar
De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report
A. Rea, G. G. Caldarola, C. Sandomenico, M. Colangelo +4 more
2002Tumori53 citations
Semantic Scholar
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
A. Morabito, V. Gebbia, M. di Maio, S. Cinieri +19 more
2013Lung Cancer52 citations
Semantic Scholar
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
G. Baldassarre, M. Barone, B. Belletti, C. Sandomenico +8 more
1999Oncogene51 citations Open access
Semantic Scholar
Cetuximab in non-small-cell lung cancer
G. Carillio, A. Montanino, R. Costanzo, C. Sandomenico +9 more
2012Expert Review of Anticancer Therapy46 citations
Semantic Scholar
Anti‐sense oligonucleotides directed against EGF‐related growth factors enhance anti‐proliferative effect of conventional anti‐tumor drugs in human colon‐cancer cells
A. De Luca, M. P. Selvam, C. Sandomenico, S. Pepe +4 more
1997International Journal of Cancer39 citations Open access
Semantic Scholar
Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors.
P. Giordano, A. Manzo, A. Montanino, R. Costanzo +9 more
2016Critical reviews in oncology/hematology37 citations
Semantic Scholar
Vandetanib: An overview of its clinical development in NSCLC and other tumors.
A. Morabito, M. Piccirillo, R. Costanzo, C. Sandomenico +10 more
2010Drugs of Today37 citations
Semantic Scholar
BRAF Inhibitors in Non-Small Cell Lung Cancer
V. Sforza, G. Palumbo, Priscilla Cascetta, G. Carillio +14 more
2022Cancers29 citations Open access
Semantic Scholar
Lurbinectedin in small cell lung cancer
A. Manzo, V. Sforza, G. Carillio, G. Palumbo +15 more
2022Frontiers in Oncology27 citations Open access
Semantic Scholar
Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.
A. Avallone, P. Delrio, B. Pecori, F. Tatangelo +11 more
2011International Journal of Radiation Oncology, Biology, Physics27 citations
Semantic Scholar
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer.
C. Gridelli, A. Rossi, M. di Maio, S. Leo +13 more
2014Clinical Lung Cancer25 citations
Semantic Scholar
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
M. di Maio, S. Signoriello, A. Morabito, A. Rossi +22 more
2012Lung Cancer20 citations
Semantic Scholar
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
P. Comella, V. Lorusso, L. Maiorino, R. Casaretti +11 more
2009Cancer Chemotherapy and Pharmacology18 citations
Semantic Scholar
Treatment of small cell lung cancer.
A. Morabito, G. Carillio, G. Daniele, M. Piccirillo +8 more
2014Critical reviews in oncology/hematology17 citations
Semantic Scholar
Central venous device-related thrombosis as imaged with MDCT in oncologic patients: prevalence and findings
O. Catalano, E. de Lutio di Castelguidone, C. Sandomenico, M. Petrillo +3 more
2011Acta Radiologica17 citations
Semantic Scholar
Capecitabine, Alone and in Combination, in the Management of Patients with Colorectal Cancer
P. Comella, R. Casaretti, C. Sandomenico, A. Avallone +1 more
2012Drugs16 citations
Semantic Scholar
Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations.
A. Morabito, R. Costanzo, A. Rachiglio, R. Pasquale +6 more
2013Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives
R. Costanzo, A. Montanino, M. di Maio, M. Piccirillo +8 more
2013Expert Review of Anticancer Therapy14 citations
Semantic Scholar
Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy
C. Mastroianni, C. Viscomi, S. Ceniti, R. De Simone +12 more
2008Patient14 citations
Semantic Scholar
Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring
Vittoria Barchiesi, V. Simeon, C. Sandomenico, M. Cantile +4 more
2021Journal of Circulating Biomarkers13 citations Open access
Semantic Scholar
Focus on Nintedanib in NSCLC and Other Tumors
A. Manzo, G. Carillio, A. Montanino, R. Costanzo +3 more
2016Frontiers in Medicine13 citations Open access
Semantic Scholar
Nuclear DNA content‐derived parameters correlated with heterogeneous expression of p53 and bcl‐2 proteins in clear cell renal carcinomas
S. Pepe, A. Ruggiero, Maria D'Acquisto, M. de Laurentiis +7 more
2000Cancer13 citations
Semantic Scholar
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet
P. Comella, R. Casaretti, R. Manzo, C. Sandomenico +3 more
2010Acta oncologica12 citations Open access
Semantic Scholar
Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working
A. Morabito, E. Mercadante, Paolo Muto, A. Manzo +16 more
2024Exploration of Targeted Anti-tumor Therapy11 citations Open access
Semantic Scholar
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
A. Morabito, G. Daniele, R. Costanzo, A. Favaretto +16 more
2017Lung Cancer10 citations
Semantic Scholar
EGFR Mutations
A. Manzo, A. Montanino, R. Costanzo, C. Sandomenico +6 more
2019Oncogenomics9 citations
Semantic Scholar
Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.
A. Morabito, C. Sandomenico, R. Costanzo, A. Montanino +8 more
2012Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.
A. Morabito, M. Piccirillo, P. Maione, A. Luciani +26 more
2019Lung Cancer7 citations
Semantic Scholar
Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….
M. di Maio, A. Morabito, M. Piccirillo, G. Daniele +6 more
2014Current pharmaceutical design6 citations
Semantic Scholar
Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer.
M. di Maio, R. Costanzo, P. Giordano, M. Piccirillo +9 more
2013Anti-Cancer Agents in Medicinal Chemistry6 citations
Semantic Scholar
Is preoperative endoscopic biliary drainage indicated for jaundiced patients with resectable pancreatic cancer?
M. De Bellis, R. Palaia, C. Sandomenico, E. di Girolamo +2 more
2012Current Drug Targets6 citations
Semantic Scholar
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
G. Palumbo, G. Esposito, G. Carillio, A. Manzo +16 more
2020Exploration of Targeted Anti-tumor Therapy5 citations Open access
Semantic Scholar
Pembrolizumab in lung cancer: current evidence and future perspectives.
G. Palumbo, G. Carillio, A. Manzo, A. Montanino +15 more
2019Future Oncology5 citations
Semantic Scholar
Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis
A. Morabito, E. Mercadante, P. Muto, G. Palumbo +20 more
2022JCO Oncology Practice4 citations
Semantic Scholar
Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer
P. Comella, B. Massidda, S. Palmeri, C. Putzu +5 more
2006Anti-Cancer Drugs4 citations Open access
Semantic Scholar
Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?
C. Picone, Annamaria Porto, R. Fusco, V. Granata +15 more
2025Cancer Control: Journal of the Moffitt Cancer Cente3 citations Open access
Semantic Scholar
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
P. Comella, B. Massidda, D. Natale, C. Putzu +9 more
2011Clinical colorectal cancer3 citations
Semantic Scholar
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion
A. Morabito, A. Manzo, A. Montanino, A. Rachiglio +14 more
2022The Oncologist2 citations Open access
Semantic Scholar
The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer
A. Manzo, G. Carillio, A. Montanino, V. Sforza +16 more
2020Expert Opinion on Drug Safety2 citations
Semantic Scholar
ITACA-S (Intergroup trial of adjuvant chemotherapy in adenocarcinoma of the stomach) trial: comparison of a sequential treatment versus a 5-FU/LV regimen for radically resecate gastric cancer. Tolerability and feasibility of a randomized study
E. Bajetta, I. Floriani, M. Di Bartolomeo, T. Pressiani +14 more
20102 citations
Semantic Scholar
CS.2.7 PALLIATIVE ENDOSCOPIC TREATMENT BY SELF EXPANDING METAL STENT (SEMS) IN PATIENTS WITH INOPERABLE MALIGNANT COLORECTAL OBSTRUCTION. ANALYSIS OF RESULTS AND PREDICTORS OF OUTCOMES IN A LARGE MULTICENTER SERIES
G. Manes, M. De Bellis, E. Masci, V. Cennamo +8 more
20102 citations
Semantic Scholar
Rationale and Design of MILES-3 and MILES-4 Studies : Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non e Small-Cell Lung Cancer
C. Gridelli, A. Rossi, M. di Maio, S. Leo +13 more
2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Costanzo×30
Invite
R. Costanzo — researcher profile on SciRah
A. Morabito×30
Invite
A. Morabito — researcher profile on SciRah
A. Montanino×26
Invite
A. Montanino — researcher profile on SciRah
M. Piccirillo×23
Invite
M. Piccirillo — researcher profile on SciRah

×20

Invite

N. Normanno — researcher profile on SciRah

Invite

A. Manzo — researcher profile on SciRah

G. Carillio×16

Invite

G. Carillio — researcher profile on SciRah

Invite

F. Perrone — researcher profile on SciRah

Invite

G. Daniele — researcher profile on SciRah

Invite

G. Rocco — researcher profile on SciRah

Invite

G. Palumbo — researcher profile on SciRah

Invite

M. di Maio — researcher profile on SciRah